Jorge Espinosa-Espinosa

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Muscular Dystrophy

Inflammatory Response

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Joann Overby, Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-Martínez, Nerea Moreno, Juan M Fernandez-Costa, Jordina Balaguer-Trias, Javier Ramon-Azcon, Manuel Pérez-Alonso, Thorleif Møller, Beatriz Llamusí, Rubén Artero
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA LR Mice. Pharmaceutics 15 (4) (2023)
Sarah Joann Overby, Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-Martínez, Nerea Moreno, Juan M Fernandez-Costa, Jordina Balaguer-Trias, Javier Ramon-Azcon, Manuel Pérez-Alonso, Thorleif Møller, Beatriz Llamusí, Rubén Artero
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA LR Mice. Pharmaceutics 15 (4) (2023)
Sarah Joann Overby, Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-Martínez, Nerea Moreno, Juan M Fernandez-Costa, Jordina Balaguer-Trias, Javier Ramon-Azcon, Manuel Pérez-Alonso, Thorleif Møller, Beatriz Llamusí, Rubén Artero
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA LR Mice. Pharmaceutics 15 (4) (2023)
Sarah Joann Overby, Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-Martínez, Nerea Moreno, Juan M Fernandez-Costa, Jordina Balaguer-Trias, Javier Ramon-Azcon, Manuel Pérez-Alonso, Thorleif Møller, Beatriz Llamusí, Rubén Artero
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA LR Mice. Pharmaceutics 15 (4) (2023)
Jorge Espinosa-Espinosa, Anchel González-Barriga, Arturo López-Castel, Rubén Artero
Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies. International journal of molecular sciences 23 (3) (2022)